Sorafenib sensitizes hepatocellular carcinoma cell to cisplatin via suppression of Wnt/β-catenin signaling
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sorafenib sensitizes hepatocellular carcinoma cell to cisplatin via suppression of Wnt/β-catenin signaling
Authors
Keywords
Hepatocellular carcinoma, Cisplatin, Sorafenib, Chemoresistance, Wnt/β-catenin
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 381, Issue 1-2, Pages 139-144
Publisher
Springer Nature
Online
2013-06-11
DOI
10.1007/s11010-013-1695-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Annexin A4 is a possible biomarker for cisplatin susceptibility of malignant mesothelioma cells
- (2012) Takuya Yamashita et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling
- (2012) Yiliang Zhang et al. HEPATOLOGY
- Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells
- (2012) Marie-José Blivet-Van Eggelpoël et al. JOURNAL OF HEPATOLOGY
- Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
- (2012) Hongjiang Wang et al. PLoS One
- The tyrosine kinase inhibitor sorafenib sensitizes hepatocellular carcinoma cells to taxol by suppressing the HURP protein
- (2011) Tzu-Ching Kuo et al. BIOCHEMICAL PHARMACOLOGY
- Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells
- (2011) K.-F. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Sorafenib Inhibits the Hepatocyte Growth Factor-Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma
- (2011) T. Nagai et al. MOLECULAR CANCER THERAPEUTICS
- The Role of Proline Rich Tyrosine Kinase 2 (Pyk2) on Cisplatin Resistance in Hepatocellular Carcinoma
- (2011) Wei Geng et al. PLoS One
- Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model
- (2010) Yu-Xiong Feng et al. HEPATOLOGY
- miR-29 Modulates Wnt Signaling in Human Osteoblasts through a Positive Feedback Loop
- (2010) Kristina Kapinas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel treatments for hepatocellular cancer
- (2009) S.H. Kerr et al. CANCER LETTERS
- Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9
- (2009) Keisuke Kohga et al. HEPATOLOGY
- Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway
- (2009) Her-Young Su et al. INTERNATIONAL JOURNAL OF CANCER
- Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
- (2009) R. C. Kane et al. ONCOLOGIST
- Acquired cisplatin resistance in the head-neck cancer cell line Cal27 is associated with decreased DKK1 expression and can partially be reversed by overexpression of DKK1
- (2008) Eva M. Gosepath et al. INTERNATIONAL JOURNAL OF CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started